期刊文献+

耳穴埋豆加溃结膏穴位贴敷联合柳氮磺胺吡啶对溃疡性结肠炎的疗效观察 被引量:5

Clinical Observation on Auricular Acupuncture Point Bean Combined with Kuijie Gao Acupoint Application and Sulfasalazine in Preventing Recurrence of Ulcerative Colitis
下载PDF
导出
摘要 目的探讨耳穴埋豆联合溃结膏穴位贴敷与柳氮磺胺吡啶对溃疡性结肠炎的疗效情况。方法选取溃疡性结肠炎患者88例(本院门诊2016年1月至2016年12月收治),电脑随机分成观察组44例、对照组44例,对照组给予柳氮磺胺吡啶治疗,观察组给予耳穴埋豆联合溃结膏穴位贴敷联合柳氮磺胺吡啶治疗,比较两组患者临床疗效情况。结果观察组治疗后1、2个月复发率2.27%、6.82%,显著低于对照组对应时间复发率(P<0.05),差异有统计学意义;治疗后两组患者临床症状评分均显著改善,观察组和对照组有显著性差异(P<0.05),差异有统计学意义;治疗后,两组结肠观察评分均显著改善,观察组较对照组有显著性差异(P<0.05);治疗后两组患者黏膜菌群均较治疗前有显著性改善,但两组间无显著性差异;观察组临床有效率95.45%(42例),对照组临床有效率59.09%(26例),观察组显著高于对照组(χ2=16.5647,P<0.05),有统计学意义。结论给予溃疡性结肠炎患者应用耳穴埋豆联合溃结膏穴位贴敷与柳氮磺胺吡啶方案治疗,可显著改善患者临床症状、肠道黏膜菌群,并且对于降低病情复发率也有显著性意义。 Objective To investigate the therapeutic effect of auricular acupoint burying with acupoint application and sulfasalazine on preventing the recurrence of ulcerative colitis. Methods Eighty-eight patients with ulcerative colitis were selected( according to our hospital from January 2016 to December 2016).The patients were randomly divided into observation group( 44 cases) and control group( 44 cases). The control group was given sulfasalazine,and the observation group The acupuncture and burying beans combined with acupoint application combined with sulfasalazine were used to compare the clinical efficacy of the two groups. Results The recurrence rate was 2. 27 % and 6. 82 % in the observation group one month and two months after treatment,which was significantly lower than the corresponding time relapse rate in the control group( P〈 0. 05). There was significant difference between the two groups. The clinical symptom scores of the two groups were significantly improved after treatment. There was a significant difference between the observation group and the control group( P〈 0. 05),with statistical significance; after the treatment,the colon observation scores of the two groups were significantly improved,and there was a significant difference between the observation group and the control group( P〈 0. 05); The mucosal flora was significantly improved compared with that before treatment,but there was no significant difference between the two groups( P〉 0. 05). The clinical effective rate was 95. 45 %( 42 cases) in the observation group and 59. 09 %( 26 cases) in the control group. The clinical effectiveness of the group was significantly higher than that of the control group( χ2=16. 5647,P〈 0. 05),which was statistically significant. Conclusion The treatment of patients with ulcerative colitis with auricular acupuncture combined with Kuijie Gao acupoint application and sulfasalazine treatment can significantly improve the clinical symptoms and intestinal mucosal flora of patients,and it also has significant significance in reducing the recurrence rate of the disease.
作者 乔虹 娄华 QIAO Hong;LOU Hun(Department of Traditional Chinese Medicine,Zhengzhou Traditional Chinese Medicine Hospital,Zhengzhou 450000 Chin)
出处 《内蒙古医学杂志》 2018年第5期536-538,共3页 Inner Mongolia Medical Journal
基金 郑州市科技攻关项目(20140522)
关键词 耳穴埋豆 溃结膏 柳氮磺胺吡啶 溃疡性结肠炎 auricular acupuncture kuijie ointment sulfasalazine ulcerative colitis
  • 相关文献

参考文献6

二级参考文献39

  • 1米娜,谈建国,姚克敏,关宏强.南京市呼吸道疾病时间序列模型的建立与分析[J].气象科技,2005,33(6):554-558. 被引量:5
  • 2李福章.甘草泻心汤加减治疗慢性结肠炎124例[J].光明中医,2006,21(11):86-86. 被引量:9
  • 3桑力轩,刘汉立,姜敏.溃疡性结肠炎发病机制研究进展[J].世界华人消化杂志,2007,15(20):2249-2254. 被引量:86
  • 4Bell Aj, Nicholls Rj, Forbes A, et al. Human lymphocyte stimula -tion with pouchitis flora is greater than with flora from a heahhypouch but is suppressed by metronidazole[ J ]. Gut ,2004, 53(12) :1801 - 1805.
  • 5Madsen K1, Doyle js, Jewell Ld, et al. Lactobacillus species pre -vents colitis in interleukin 10 gene -deficientm ice[ J]. Gas- troen - ter01ogy ,2006,116 : 1107 - 1114.
  • 6Rioux Kp, I%dorak Rn. Probiotics in the treatment of inflam - matory bowel disease [ J ] J Clin Gastroenterol, 2006,40 : 260 - 263.
  • 7Staerk Laursen L1, Stokholm M, Bukhave K, et al. Disposition of 5- aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion. Gut, 1990,31(11): 1271-1276.
  • 8Ardizzone S, Dolodo P, Ranzi T, et al. Mesalazine foam (salofalk foam) in the treatment of active distal ulcerative colitis: a compara- tive trial vs Salofalk enema. The SAF23 study group. Ital J Gas- troenterol Hepatol, 1999,31(8):677-684.
  • 9Gisbert JP, Gomollon F, Mate J, et al. Role of 5-aminosalicylic acid (5-ASA) in treatment of inflammatory bowel disease: a systematic review. Dig Dis Sci, 2002,47(3):471-488.
  • 10Sandbom WJ, Hanauer SB. Systematic review: the pharmacoki-net- ic profiles of oral mesalazine formulations and mesalazine pro- drugs used in the management of ulcerative colitis. Aliment Pharmacol Ther, 200337(1):29-42.

共引文献74

同被引文献61

引证文献5

二级引证文献32

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部